Us Congress 2025-2026 Regular Session

House Energy and Commerce Subcommittee on Health Bills & Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB51

Introduced
1/6/23  
Refer
1/9/23  
Washington, D.C. Admission Act This bill provides for the admission of the state of Washington, Douglass Commonwealth into the United States. The commonwealth consists of all the territory of the District of Columbia (DC), excluding certain federal property. The excluded property shall be known as the Capital and serve as the seat of federal government; it includes the principal federal monuments, the White House, the Capitol Building, the Supreme Court Building, and the federal office buildings located adjacent to the Mall and Capitol Building. In addition, the bill maintains the federal government's authority over military lands and specified other property and prohibits the commonwealth from taxing federal property except as permitted by Congress. Within 30 days of this bill's enactment, the DC mayor must call for the election of two Senators and one Representative for the commonwealth. The commonwealth shall be admitted into the United States upon a presidential proclamation announcing the results of that election. The bill applies current DC laws to the commonwealth and continues pending judicial proceedings. It also continues certain federal authorities and responsibilities, including regarding employee benefits, agencies, and courts, until the commonwealth certifies that it is prepared to take over those authorities and responsibilities. Further, the bill provides for expedited consideration of a joint resolution to repeal the Twenty-third Amendment to the Constitution (which allows DC citizens to vote in presidential elections). The bill also establishes a commission to advise the President, Congress, and DC and commonwealth leaders on the transition.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB46

Introduced
1/9/23  
Refer
1/9/23  
Mental Health Access and Gun Violence Prevention Act of 2023 This bill authorizes FY2024 appropriations for the Department of Justice, the Department of Health and Human Services, and the Social Security Administration to (1) increase access to mental health care treatment and services, and (2) promote reporting of mental health information to the National Instant Criminal Background Check System. (This system is used to query federal, state, local, tribal, and territorial criminal history record information and other records to determine an individual's eligibility to receive, transfer, or possess firearms.)
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB384

Introduced
1/17/23  
Refer
1/17/23  
Protecting Life from Chemical Abortions Act This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention. The bill also generally prohibits the declaration of a public health emergency with respect to abortions.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB116

Introduced
1/9/23  
Refer
1/9/23  
Pregnant Women Health and Safety Act of 2023 This bill establishes requirements for physicians who perform abortions and abortion clinics. Specifically, the bill requires a physician who performs an abortion (1) to have admitting privileges at a nearby hospital; and (2) at the time of the abortion, to notify the patient of the hospital location where the patient can receive follow-up care if complications arise. A physician who fails to comply is subject to criminal penalties—a fine, a prison term of up to two years, or both. A woman who undergoes an abortion may not be prosecuted. The bill also requires an abortion clinic, in order to receive federal funds or assistance, to (1) be licensed by the state in which it is located, and (2) be in compliance with federal standards for ambulatory surgical centers.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB35

Introduced
1/9/23  
Refer
1/9/23  
Close the Medigap Act of 2023 This bill (1) expands guaranteed issue rights with respect to Medigap policies (Medicare supplemental health insurance policies), (2) eliminates certain limitations on Medigap policies for newly eligible Medicare beneficiaries, and (3) modifies other provisions related to Medigap policies. (Guaranteed issue rights require that a policy be offered to any eligible applicant without regard to health status.)
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB74

Introduced
1/9/23  
This bill prohibits the use of federal funds to implement or enforce mandates that require individuals to wear face coverings or receive vaccinations to prevent the spread of COVID-19 (i.e., coronavirus disease 2019). The bill provides for an exception that applies in health care settings.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB72

Introduced
1/9/23  
Refer
1/9/23  
This bill prohibits the use of federal funds to maintain a database or collect information that can be used to identify an individual's COVID-19 (i.e., coronavirus disease 2019) vaccination status.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB117

Introduced
1/9/23  
Refer
1/9/23  
This bill prohibits any entity that receives specified COVID-19 relief funds from mandating COVID-19 vaccines for its employees. An entity that violates this prohibition must return the funding it received.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB177

Introduced
1/9/23  
Refer
1/9/23  
This bill requires the Centers for Medicare & Medicaid Services to revise regulations so as to specifically require Medicare skilled nursing facilities and Medicaid nursing facilities to report the identity of medical directors and related information.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB125

Introduced
1/9/23  
Refer
1/9/23  
Refer
1/20/23  
Refer
2/1/23  
Travel Mask Mandate Repeal Act of 2023 This bill prohibits federal agencies from mandating the use of masks or face coverings on planes, trains, buses, and other public conveyances and at transportation hubs to prevent the transmission of COVID-19. Specifically, the bill nullifies (1) the rule issued by the Centers for Disease Control and Prevention (CDC) on January 29, 2021, that mandates such use of masks or face coverings; and (2) orders and directives of the Transportation Security Administration that relate to the CDC rule.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB207

Introduced
1/9/23  
Refer
1/9/23  
Advanced Safe Testing at Residence Telehealth Act of 2023 This bill temporarily establishes several programs to provide telehealth services for at-home testing, evaluations, and other health care. Specifically, the bill establishes a demonstration program to provide assistive telehealth consultations and home- and community-based care for certain Medicare beneficiaries through Medicare Advantage (MA) plans. Covered services include certain at-home diagnostic tests, telehealth consultations, transportation services, and meal benefits. Beneficiaries must be (1) age 65 or older and eligible to enroll in a qualifying MA plan and to receive certain low-income subsidies under the Medicare prescription drug benefit, or (2) dually eligible for Medicare and Medicaid benefits. The bill also establishes a grant program for state Medicaid programs to cover similar at-home tests and related telehealth consultations. Additionally, the Department of Veterans Affairs must establish a pilot program to provide tests and related telehealth consultations free of charge to veterans.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB128

Introduced
1/9/23  
Refer
1/9/23  
Defund Planned Parenthood Act of 2023 This bill restricts federal funding for Planned Parenthood Federation of America Inc. or any of its affiliates or clinics for one year. Specifically, it prohibits funding those entities unless they certify that the affiliates and clinics will not perform, and will not provide funds to entities that perform, abortions during that year. If the certification requirement is not met, the Department of Health and Human Services and the Department of Agriculture must recoup any federal assistance received by those entities. However, the bill's funding restriction does not apply to abortions performed in cases of rape or incest or when necessary to resolve a physical condition that endangers a woman's life. The bill also provides additional funding for community health centers for the one-year period. These funds are subject to the same abortion-related restrictions and exceptions.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB170

Introduced
1/9/23  
Refer
1/9/23  
Domestic Security Using Production Partnerships and Lessons from Yesterday Act of 2023 or the Domestic SUPPLY Act of 2023 This bill establishes a program and sets out other requirements to promote domestic manufacturing of personal protective equipment (PPE) for infectious diseases and other public health emergencies. The Department of Health and Human Services (HHS) must establish a program to enter into purchasing agreements for PPE produced domestically by manufacturers that are majority-owned and -operated by U.S. citizens. HHS must coordinate with the Department of Defense and the Department of Homeland Security on this program. In addition, the federal government must only procure, subject to limited exceptions, PPE that is produced domestically to prevent the transmission of an infectious disease. If using federal funds, states or localities must also procure PPE domestically. Further, the bill requires HHS to consult with the Occupational Safety and Health Administration on a report about changes to federal requirements for PPE during the COVID-19 pandemic and the impact of those changes on health care workers who cared for patients in 2020 and 2021.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB229

Introduced
1/9/23  
Refer
1/9/23  
World Deserves To Know Act This bill requires sanctions on certain members of the Chinese Communist Party (CCP) and officials of Chinese health agencies. It also addresses related issues. The President must impose visa- and property-blocking sanctions on any foreign person who is a CCP official and who is knowingly responsible for or complicit in (1) the disappearances of whistleblowers and citizen journalists in China relating to COVID-19, or (2) limiting free speech and academic freedom in China relating to COVID-19. The President must also impose such sanctions on specified individuals who have leadership positions in China's Center for Disease Control and Prevention and China's National Health Commission (NHC). The authority to impose such sanctions shall end when the President certifies to Congress that an independent and unimpeded investigation into the potential origin of COVID-19 from the Wuhan Institute of Virology has taken place. The bill also bars federal funds and certain federal student assistance from going to institutions of higher education that enter into a contract with any element or China-based affiliate of the NHC. Federal funding to the National Academy of Sciences may not be used to enter into a contract with any element or China-based affiliate of the NHC. The Government Accountability Office must report to Congress a review of all funds that the National Institutes of Health have made available to the NHC since FY2010. This report must also be publicly available.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB197

Introduced
1/9/23  
Refer
1/9/23  
Rural Telehealth Expansion Act This bill expands coverage of telehealth services under Medicare to include store-and-forward technologies (in which information is sent to providers and reviewed at a later time, rather than through a real-time interaction). Currently, coverage is limited to federal demonstration programs in Alaska and Hawaii.